FIELD: medicine.
SUBSTANCE: what is described is an antiviral emulsion agent based on interferon inducer for topical application. The base contains Vaseline or Vaseline oil, T-2 emulsifier, as well as a solution of amphiphilic complex or single-chain high-polymeric RNA of Saccharomyces cerevisiae containing short double-stranded regions with oleic acid enriched with sodium oleate (up to 10%).
EFFECT: prolonging the shelf life of the above agent.
1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIHERPETIC AGENT | 2012 |
|
RU2502504C1 |
ANTIVIRAL AGENT FOR PREVENTION OF INFECTIOUS BOVINE RHINOTRACHEITIS | 2014 |
|
RU2571935C1 |
SOAPY AMPHIPHILIC INTERFERON GAMMA INDUCER PENETRATING READILY THROUGH BIOLOGICAL MEMBRANES | 2012 |
|
RU2496783C1 |
METHOD OF PRODUCING AMPHIPHILIC HIGHLY POLYMERIC RNA FROM DRY YEAST | 2022 |
|
RU2801533C1 |
ANTIVIRAL AGENT | 2010 |
|
RU2436583C1 |
ANTIVIRAL AGENT | 1996 |
|
RU2123339C1 |
METHOD OF TREATING AVIAN INFLUENZA | 2012 |
|
RU2502512C2 |
METHOD OF TREATING VIRAL DISEASES OF AMPHIPHILIC HIGH-POLYMER YEAST RNA PACKED IN NANOSIZED CHITOSAN CAPSULES, PER'OS | 2023 |
|
RU2823882C1 |
METHOD OF TREATING POX | 2012 |
|
RU2480219C1 |
METHOD FOR PRODUCING BIOLOGICALLY ACTIVE COMPONENTS FROM YEAST CELLS SACCHAROMYCES CEREVISIAE AND A THERAPEUTIC AGENT BASED THEREON | 2018 |
|
RU2722731C2 |
Authors
Dates
2016-02-10—Published
2014-11-17—Filed